(NEXSTAR) – Lupin Pharmaceuticals Inc. is voluntarily recalling a blood pressure medication that possibly contains high levels of a cancer-causing impurity, according to the U.S. Food and Drug ...

Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg because ...

Aurobindo Pharma issued a voluntary recall of 22 batches of Irbesartan, a drug used in the treatment of hypertension, due to the presence of an impurity linked to cancer, according to LiveMint.com.

ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being ...

Eight lots of a certain blood pressure medication have been recalled. That's after testing showed it contained trace amounts of a cancer-causing material. Prinston Pharmaceuticals announced one lot of ...

Prinston Pharmaceuticals has recalled one lot of Irbesartan and seven lots of Irbesartan HCTZ, the company announced in a news release. The medications are used to control high blood pressure and ...

Another heart medication is under recall because it could contain a cancer-causing chemical. ScieGen Pharmaceuticals is voluntarily recalling certain lots of Irbesartan Tablets. The company said the ...

Baltimore, Maryland, October 14, 2021: Lupin Pharmaceuticals Inc. is voluntarily recalling the below-mentioned batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the ...